Moderna: agreement with Cenra Healthcare in Taiwan

(CercleFinance.com) - Moderna and Cenra Healthcare (the sales and marketing arm of Cenra Inc.
) have announced an agreement to co-promote Moderna's mRNA respiratory vaccines in Taiwan, including Spikevax, the COVID-19 vaccine.

Under the agreement, Moderna will manufacture and distribute its vaccines, while Cenra Healthcare will promote them and conduct medical education activities.

The agreement, which runs until July 2027, aims to improve access to vaccines across Taiwan.

Moderna says it looks forward to partnering with Cenra to strengthen public health initiatives and raise awareness of vaccination against respiratory diseases.

Copyright (c) 2024 CercleFinance.com. All rights reserved.